ATS 2019 Virtual Final Program

P91 Mortality Is Underestimated in Cirrhosis Patients with Acute on Chronic Liver Failure According to Physician Survey/ S. Burke, A.C. Miller, S. Patolia, St. Louis, MO, p.A1670 P92 Hemophagocytic Lymphohistiocytosis (HLH) in the MICU: A Single Institution Cohort Study on Mortality and Liver Failure/ N. Al Nasrallah, C.R. Sears, Indianapolis, IN, p.A1671 Facilitators : D.W. Ford, MD, Charleston, SC J.M. Dianti, MD, Caba, Argentina P93 A Novel Multidisciplinary Approach - Medical Intensive Liver Unit ( MILU)/ A. Kapoor, Cleveland, OH, p.A1672 P94 Diffuse Alveolar Hemorrhage in Stem Cell Transplant Recipients/ Z. Zhang, C. Wang, A.S. Niven, H. Yadav, Rochester, MN, p.A1673 P95 Outcomes of Prothrombin Complex Concentrates (PCC) in Septic Coagulopathy: It Won’t Work Where It Never Meant To/ I. Kourouni, D. Pan, M. Friedman, D. Steiger, R. Ernest Jean, New York, NY, p.A1674 P96 A Retrospective Study to Identify Early Predictors of Mortality in Sickle Cell Disease Patients Admitted to the Intensive Care Unit/ J. Rosentsveyg, J.L. Simonson, S.Y. Chung, S.J. Koenig, G.Z. Zaidi, New Hyde Park, NY, p.A1675 P97 Relationship Between Sodium Chloride Use, Hyperchloremia, and Time to Resolution of Diabetic Ketoacidosis/ G. Sheikh, J. Tsui, R.J. Bernardo, U.Z. Bhutta, B.R. Brown, Oklahoma City, OK, p.A1676 P98 Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats/ S. Piel, J. Janowska, J.K. Ehinger, M. Karlsson, T.J. Kilbaugh, Philadelphia, PA, p.A1677 P99 Morbidity and Mortality in Patients with Pre-Intervention Upper GI Bleed Receiving Continuous IV Proton Pump Inhibitor versus Twice Daily Dosing/ A. Ammar, S.D. Bali, Y. Galili, M. Lytle, E. Albaddawi, R.A. Khan, Orlando, FL, p.A1678 P100 Quality Improvement Project to Increase Serum Phosphate Monitoring in the Intensive Care Unit at a Veterans Affairs Hospital/ J.S. Prudom, U.K. Ghori, J. Rodriguez-Hernandez, S. Jones, W. Blaser, M. Lopez-Quintero, T.M. Ferrer-Marrero, Milwaukee, WI, p.A1679 P101 Plasmatic Sodium Behaviour During the Recovery of Renal Function in Critically Ill Adult Patients/ N. Angeloni, F.D. Masevicius, Buenos Aires, Argentina, p.A1680 P102 Antiepileptic Drugs for Primary Seizure Prevention After Spontaneous Intracranial Hemorrhage: A Systematic Review and Meta-Analysis/ F. Angriman, B. Kumar Tirupakuzhi Vijayaraghavan, L. Dragoi, C. Lopez Soto, M. Chapman, D.C. Scales, Toronto, Canada, p.A1681 P103 Predictors of Suppressive Wave Form on Electroencephalogram in Intensive Care Unit Patients with Encephalopathy/ B. Balakrishnan, T. Kohal, J.H. Jennings, Detroit, MI, p.A1682 Facilitators : P.M. Dodek, MD, Vancouver, Canada B.L. Ferreyro, MD, Toronto, Canada P104 Predictors of SubClinicalSeizures on Electroencephalograms in Intensive Care Unit Patients with Encephalopathy/ T. Kohal, B. Balakrishnan, J.H. Jennings, Detroit, MI, p.A1683 P105 Patterns and Significance of Abnormal Liver Function Test in Decompensated Diabetes Mellitus/ R. Ogunti, A. Awan, H. Yaqoob, P. Wessly, K. Binu, M. Munawwar, B. Ahmad, Y. Gebrekidan, V. Kodadhala, V. Poddar, Washington, DC, p.A1684 P106 Risk Factors for Hyperglycemia in Medically Critically Ill Patients/ R.L. Sabang, C. Becker, Valhalla, NY, p.A1685 P107 Development and Preliminary Assessment of Training Advanced Care Practitioners in Adult Critical Care Medicine/ V. Pathak, C. Zhou, Raleigh, NC, p.A1686 P108 Screening for DVT in the Neurocritically Ill: Is It Justified?/ A. Martin, R. Velasquez, O. Epelbaum, D. Chandy, Valhalla, NY, p.A1687 P109 Utility of Deep Venous Thrombosis Testing for Unexplained Fever in the Neurocritically Ill/ R. Velasquez, A. Martin, D. Chandy, O. Epelbaum, Valhalla, NY, p.A1688 P110 Feasibility of Use Urine Collection Strips in Critically-Ill Children for the Measurement of Diurnal Hormones/ E. Quigley, K. Glotzbach, D. Zava, E. Hirschberg, Salt Lake City, UT, p.A1689 P111 Serum Estradiol Concentrations in Male Subjects with Cirrhosis and Critical Illness/ G.B. Pereira, J. Barney, Birmingham, AL, p.A1690 P112 Perils of Long-Term Follow-Up of Patients with Life-Threatening, Inhalation-Induced Synthetic Cannabinoids-Associated Coagulopathy in Chicago, Illinois/ M. Tole, S. LaBedz, I. Rubinstein, Chicago, IL, p.A1691 P113 Impact of Insurance Type on Undergoing Chemotherapy and Radiation in Lung Cancer Patients Receiving Care at the NCI Designated Cancer Center in New Mexico/ A. Wright, E. Sheehan, A.I. Saeed, F. Qeadan, L. Statler, Albuquerque, NM, p.A1692 P114 A Case Series of Amlodine Overdose in a Tertiary Center/ J. Allgaier, F. Katsikeris, M.J.S. Farmer, Springfield, MA, p.A1693 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION A45 CRITICAL CARE: OF MICE AND MEN - INSIGHTS FROM EXPERIMENTAL AND ANIMAL MODELS IN ARDS AND SEPSIS 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : H. Zhang, MD, PhD, Toronto, Canada J.K. Juss, MD, PhD, Toronto, Canada P116 Natural History of Chlorine Gas Inhalation in Ovine Model: Dose and Gender Dependency Study/ T. Baljinnyam, F. Satoshi, Y. Niimi, J. Salsbury, C. Ouellette, Y. Hirasawa, C. Anderson, P. Donald, G. Edwin, A. Salzman, P. Enkhbaatar, Galveston, TX, p.A1694 ATS 2019 • Dallas, TX 62 SUNDAY • MAY 19